These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

149 related items for PubMed ID: 307737

  • 1. [The clinical significance of soluble nuclear antigen specific antibodies (author's transl)].
    Peltier AP, Gaudreau A, Amor B, Kahn MF, Ryckewaert A, Sany J, Haim T.
    Nouv Presse Med; 1978 May 27; 7(21):1813-8. PubMed ID: 307737
    [Abstract] [Full Text] [Related]

  • 2. [Significance of speckled staining of epidermal nuclei in direct immunofluorescence. 10 cases (author's transl)].
    Morel P, Peltier AP, Allegre P, Civatte J.
    Nouv Presse Med; 1978 May 27; 7(27):2377-80. PubMed ID: 353722
    [Abstract] [Full Text] [Related]

  • 3. Association of antibodies to ribonucleoprotein and Sm antigens with mixed connective-tissue disease, systematic lupus erythematosus and other rheumatic diseases.
    Sharp GC, Irvin WS, May CM, Holman HR, McDuffie FC, Hess EV, Schmid FR.
    N Engl J Med; 1976 Nov 18; 295(21):1149-54. PubMed ID: 1086429
    [Abstract] [Full Text] [Related]

  • 4. [Sharp's syndrome: a new entity amongst the connective tissue diseases?].
    Kahn MF, Peltier AP, Appelboom T.
    Nouv Presse Med; 1975 Jun 21; 4(25):1863-5. PubMed ID: 1080278
    [Abstract] [Full Text] [Related]

  • 5. Mixed connective tissue disease.
    Minkin W, Rabhan N.
    Arch Dermatol; 1976 Nov 21; 112(11):1535-8. PubMed ID: 1086651
    [Abstract] [Full Text] [Related]

  • 6. [Dysimmune rheumatism in Raynaud's syndrome (inflammatory rheumatism, Raynaud's syndrome, speckled antinuclear factors and anti-ribonucleoprotein antibody): a new syndrome?].
    Appelboom T, Kahn MF, Peltier AP, de SEZE S.
    Ann Med Interne (Paris); 1974 Nov 21; 125(11):841-8. PubMed ID: 4218716
    [No Abstract] [Full Text] [Related]

  • 7. [Significance of anti-centromere antibodies. Clinical value].
    Meyer O, Haim T, Ryckewaert A.
    Rev Rhum Mal Osteoartic; 1983 Apr 21; 50(4):261-6. PubMed ID: 6348931
    [Abstract] [Full Text] [Related]

  • 8. [The Sharp syndrome ("mixed connective tissue disease")].
    Rosenthal M.
    Schweiz Med Wochenschr; 1976 Jan 31; 106(5):129-34. PubMed ID: 1082643
    [Abstract] [Full Text] [Related]

  • 9. Symptomatology and diagnosis in connective tissue disease. Antibodies to extractable ribonucleoprotein in 123 patients reacting with cell nuclei in the immunofluorescence test.
    Jonsson J.
    Scand J Rheumatol; 1976 Jan 31; 5(3):177-83. PubMed ID: 790556
    [Abstract] [Full Text] [Related]

  • 10. [The clinical significance of anti-ENA antibodies and anticentromere antibody (ACA) in patients with sclerodermatous skin changes and Raynaud's phenomenon].
    Uchida K, Kondo H, Kashiwazaki S.
    Ryumachi; 1984 Aug 31; 24(4):241-9. PubMed ID: 6334895
    [No Abstract] [Full Text] [Related]

  • 11. Clinical significance of antibodies to soluble extractable nuclear antigens (anti-ENA).
    Gaudreau A, Amor B, Kahn MF, Ryckewaert A, Sany J, Peltier AP.
    Ann Rheum Dis; 1978 Aug 31; 37(4):321-7. PubMed ID: 308354
    [Abstract] [Full Text] [Related]

  • 12. Significance of anti-ENA, Sm and RNP antibodies in patients with antinuclear antibodies.
    Levo Y, Lotan C.
    Isr J Med Sci; 1982 Feb 31; 18(2):287-9. PubMed ID: 6978327
    [No Abstract] [Full Text] [Related]

  • 13. Antibodies to components of extractable nuclear antigen. Clinical characteristics of patients.
    Farber SJ, Bole GG.
    Arch Intern Med; 1976 Apr 31; 136(4):425-31. PubMed ID: 1083722
    [Abstract] [Full Text] [Related]

  • 14. Clinical usefulness of antibodies to U1snRNP proteins in mixed connective tissue disease and systemic lupus erythematosus.
    Margaux J, Hayem G, Palazzo E, Chazerain P, De Bandt M, Haim T, Kahn MF, Meyer O.
    Rev Rhum Engl Ed; 1998 Jun 31; 65(6):378-86. PubMed ID: 9670329
    [Abstract] [Full Text] [Related]

  • 15. Patterns of clinical disease associated with antibodies to nuclear ribonucleoprotein.
    Maddison PJ, Mogavero H, Reichlin M.
    J Rheumatol; 1978 Jun 31; 5(4):407-11. PubMed ID: 310884
    [Abstract] [Full Text] [Related]

  • 16. Antibodies against extractable nuclear antigens (ENA) in systemic scleroderma.
    Jabłońska S, Błaszczyk M, Górkiewicz A, Jarzabek-Chorzelska M, Rzesa G, Chorzelski T.
    Arch Immunol Ther Exp (Warsz); 1978 Jun 31; 26(1-6):765-8. PubMed ID: 312085
    [Abstract] [Full Text] [Related]

  • 17. [Renal histology in 44 patients with specific antibodies of soluble nuclear antigens].
    Meyer O, Gaudreau A, Peltier AP.
    Rev Rhum Mal Osteoartic; 1980 Oct 31; 47(10):561-8. PubMed ID: 6970963
    [Abstract] [Full Text] [Related]

  • 18. Clinical and serological heterogeneity in patients with anticentromere antibodies.
    Miyawaki S, Asanuma H, Nishiyama S, Yoshinaga Y.
    J Rheumatol; 2005 Aug 31; 32(8):1488-94. PubMed ID: 16078324
    [Abstract] [Full Text] [Related]

  • 19. The incidence and clinical significance of antibodies to extractable nuclear antigens.
    Hamburger M, Hodes S, Barland P.
    Am J Med Sci; 1977 Aug 31; 273(1):21-8. PubMed ID: 300568
    [Abstract] [Full Text] [Related]

  • 20. Identification of a SmD3 epitope with a single symmetrical dimethylation of an arginine residue as a specific target of a subpopulation of anti-Sm antibodies.
    Mahler M, Fritzler MJ, Blüthner M.
    Arthritis Res Ther; 2005 Aug 31; 7(1):R19-29. PubMed ID: 15642139
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.